These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2403414

  • 21. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.
    Cancer Res; 1990 Mar 15; 50(6):1822-7. PubMed ID: 2407345
    [Abstract] [Full Text] [Related]

  • 22. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.
    Ruan S, O'Donoghue JA, Larson SM, Finn RD, Jungbluth A, Welt S, Humm JL.
    J Nucl Med; 2000 Nov 15; 41(11):1905-12. PubMed ID: 11079503
    [Abstract] [Full Text] [Related]

  • 23. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 24. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM, Kaltovich FA, Shih LB, Fand I, Govelitz G, Goldenberg DM.
    Cancer Res; 1988 Jun 01; 48(11):3270-5. PubMed ID: 3365705
    [Abstract] [Full Text] [Related]

  • 25. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 01; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 26. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.
    Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231
    [Abstract] [Full Text] [Related]

  • 27. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
    Hauck ML, Dewhirst MW, Bigner DD, Zalutsky MR.
    Clin Cancer Res; 1997 Jan 01; 3(1):63-70. PubMed ID: 9815539
    [Abstract] [Full Text] [Related]

  • 28. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
    Hwang KM, Fodstad O, Oldham RK, Morgan AC.
    Cancer Res; 1985 Sep 01; 45(9):4150-5. PubMed ID: 4028007
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2005 Nov 01; 46(11):1907-15. PubMed ID: 16269606
    [Abstract] [Full Text] [Related]

  • 30. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.
    Baxter LT, Zhu H, Mackensen DG, Jain RK.
    Cancer Res; 1994 Mar 15; 54(6):1517-28. PubMed ID: 8137258
    [Abstract] [Full Text] [Related]

  • 31. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
    Pedley RB, Hill SA, Boxer GM, Flynn AA, Boden R, Watson R, Dearling J, Chaplin DJ, Begent RH.
    Cancer Res; 2001 Jun 15; 61(12):4716-22. PubMed ID: 11406542
    [Abstract] [Full Text] [Related]

  • 32. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.
    McCabe RP, Peters LC, Haspel MV, Pomato N, Carrasquillo JA, Hanna MG.
    Cancer Res; 1988 Aug 01; 48(15):4348-53. PubMed ID: 3390831
    [Abstract] [Full Text] [Related]

  • 33. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y.
    Cancer Res; 2000 Oct 01; 60(19):5565-70. PubMed ID: 11034104
    [Abstract] [Full Text] [Related]

  • 34. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 35. Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.
    Gold DV, Alisauskas R, Sharkey RM.
    Cancer Res; 1995 Mar 01; 55(5):1105-10. PubMed ID: 7866995
    [Abstract] [Full Text] [Related]

  • 36. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B, Mach JP, Mani JC, Ychou M, Folli S, Artus JC, Pèlegrin A.
    Cancer Res; 1996 Oct 15; 56(20):4758-65. PubMed ID: 8840995
    [Abstract] [Full Text] [Related]

  • 37. Accumulation enhancement of human monoclonal antibody HB4C5 to lung tumor xenografts by N-deglycosylation.
    Kusakabe K, Kanaya K, Sato S, Kato M, Mochizuki K, Hashizume S, Yasumoto K, Murakami H, Nomoto K.
    J Nucl Med; 1994 Feb 15; 35(2):289-95. PubMed ID: 8295001
    [Abstract] [Full Text] [Related]

  • 38. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
    Al Saati T, Blancher A, Calvas P, Neulat-Duga I, Delsol G.
    Ann Pathol; 1987 Feb 15; 7(1):1-8. PubMed ID: 3040026
    [Abstract] [Full Text] [Related]

  • 39. Tumorigenicity in athymic mice of the human colon carcinoma cell line SW1116 expressing the tumor-associated antigenic determinant CA 19-9.
    Klug TL, Salzman S, Quinn A, Melincoff GA, Sedmak DD, Tubbs RR, Zurawski VR.
    Cancer Res; 1984 Nov 15; 44(11):5212-8. PubMed ID: 6207914
    [Abstract] [Full Text] [Related]

  • 40. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
    Horak E, Hartmann F, Garmestani K, Wu C, Brechbiel M, Gansow OA, Landolfi NF, Waldmann TA.
    J Nucl Med; 1997 Dec 15; 38(12):1944-50. PubMed ID: 9430475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.